Society of Hematologic Oncology Eighth Annual Meeting
September 9–12, 2020 • Hilton Americas • Houston, Texas, USA
The eighth annual meeting of the Society of Hematologic Oncology (SOHO 2020) is scheduled for September 9–12, 2020. Organized by its founders and world class committees, SOHO is the only international society specific to the field of hematologic malignancies. Due to the worldwide COVID-19 pandemic, SOHO 2020 will be held in a virtual space rather than in-person this year.
SOHO is the premier meeting that focuses specifically on new advances and practical clinical applications in the field of hematologic malignancies. The speakers are a multidisciplinary group of internationally recognized experts that represent the spectrum of these diseases. Content will include live lectures, debates, plenary sessions, question/answer discussions, a virtual poster session, an interactive exhibit hall and other features. This year, we expect more than 1,500 physicians, nurses and related healthcare specialists to attend the 3.5-day meeting and participate in a number of unique educational formats including General Sessions, Meet-the-Professor Sessions, Live Debates, Expert Sessions, Live Plenary and Oral Abstract Presentations and other interactive and informal exchanges.
Topics will cover the latest advances in the pathophysiology and therapy of leukemias, lymphomas, myeloma, myeloproliferative neoplasms, myelodysplastic syndromes, advances in cellular therapy and exciting developments in clinical and basic research.
Message from the Chairpersons
On behalf of the organizing committees, it is our pleasure to invite you to attend the eighth annual meeting of the Society of Hematologic Oncology (SOHO). As many of you know, SOHO was established in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies. Since that time, SOHO has grown from a membership base of 400 to nearly 4,000 in 2020.
The theme of this year’s meeting is “Molecular Classification and Precision Therapy .” The program will focus on new advances and practical clinical applications, with special emphasis on novel biological and therapeutic approaches, for patients with hematologic malignancies. In addition, the speakers are a multidisciplinary group of internationally recognized experts that represent the spectrum of these diseases.
During this 3.5-day event, attendees will participate in a number of educational sessions including didactic lectures, meet-the-professor sessions, debates, plenary sessions, poster presentations, oral abstract presentations and other interactive and informal exchanges. Topics will include Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Hodgkin Lymphoma, T-Cell Lymphoma, Mantle Cell Lymphoma, Aggressive B-Cell Lymphoma, Indolent B-Cell Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Multiple Myeloma and Cellular Therapy.
We hope you will find the meeting productive, informative and enjoyable. We would like to thank all SOHO members, attendees and industry partners whose contributions and participation have been essential to the success of SOHO.
We look forward to an exciting meeting.
With warmest regards,